1. Home
  2. LITB vs INTS Comparison

LITB vs INTS Comparison

Compare LITB & INTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LITB

LightInTheBox Holding Co. Ltd.

N/A

Current Price

$3.03

Market Cap

57.1M

ML Signal

N/A

Logo Intensity Therapeutics Inc.

INTS

Intensity Therapeutics Inc.

HOLD

Current Price

$3.83

Market Cap

13.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LITB
INTS
Founded
2007
2012
Country
Singapore
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
57.1M
13.7M
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
LITB
INTS
Price
$3.03
$3.83
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
$38.00
AVG Volume (30 Days)
5.6K
25.8K
Earning Date
05-12-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$14.50
N/A
Revenue Next Year
$11.59
N/A
P/E Ratio
$10.96
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.63
$0.22
52 Week High
$4.17
$8.06

Technical Indicators

Market Signals
Indicator
LITB
INTS
Relative Strength Index (RSI) 44.52 40.32
Support Level $2.82 $3.51
Resistance Level $2.97 $5.00
Average True Range (ATR) 0.13 0.14
MACD -0.01 -0.03
Stochastic Oscillator 3.39 30.08

Price Performance

Historical Comparison
LITB
INTS

About LITB LightInTheBox Holding Co. Ltd.

LightInTheBox Holding Co Ltd is a e-commerce company, providing a diverse range of affordable lifestyle products directly to consumers. Its brands include Ador, a women's fashion brand targeting women aged 35-55; the second is a golf apparel brand focusing on female golfers aged 35 and above; the third is a women's light party dress brand for the age group of 30 and above. It offers customers products through websites and mobile applications. The company operates and reviews its performance in two segments: Product sales which consisted of online retailing of consumer products and sales to third-party sellers, and Services which consisted of the provision of logistic services to companies and individual customers.

About INTS Intensity Therapeutics Inc.

Intensity Therapeutics Inc is a late-stage clinical biotechnology company passionately committed to applying scientific leadership in the field of localized cancer reduction to anti-cancer immune activation. Its new approach involves the direct injection into tumors of a product created from DfuseRxSM discovery platform. Its platform creates patented anti-cancer product candidates comprising active anti-cancer agents and amphiphilic molecules. Its product candidate, INT230-6 comprised of three components: cisplatin, a anti-cancer cytotoxic agent, vinblastine sulfate, also a anti-cancer cytotoxic agent, and an amphiphilic molecule which enables the two cytotoxic agents to disperse through a tumor and diffuse into cancer cells following a direct intratumoral injection.

Share on Social Networks: